Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Hypha Labs (FUNI) EBT (2016 - 2025)

Hypha Labs filings provide 15 years of EBT readings, the most recent being -$558415.0 for Q3 2025.

  • On a quarterly basis, EBT fell 16.88% to -$558415.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.1 million, a 126.37% decrease, with the full-year FY2025 number at -$3.1 million, down 128.69% from a year prior.
  • EBT hit -$558415.0 in Q3 2025 for Hypha Labs, up from -$562023.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $18201.0 in Q1 2021 to a low of -$1.3 million in Q4 2024.
  • Median EBT over the past 5 years was -$277603.0 (2021), compared with a mean of -$359097.1.
  • Biggest five-year swings in EBT: surged 102.89% in 2021 and later tumbled 7928.8% in 2025.
  • Hypha Labs' EBT stood at -$277603.0 in 2021, then surged by 35.23% to -$179809.0 in 2022, then grew by 13.87% to -$154877.0 in 2023, then tumbled by 764.97% to -$1.3 million in 2024, then soared by 58.32% to -$558415.0 in 2025.
  • The last three reported values for EBT were -$558415.0 (Q3 2025), -$562023.0 (Q2 2025), and -$641822.0 (Q1 2025) per Business Quant data.